Evidence map›Paper›PMID 27572839›Full record

ArticleNature microbiology2016

Microbially cleaved immunoglobulins are sensed by the innate immune receptor LILRA2.

Kouyuki Hirayasu, Fumiji Saito, Tadahiro Suenaga, Kyoko Shida, Noriko Arase, Keita Oikawa, Toshifumi Yamaoka, Hiroyuki Murota, Hiroji Chibana, Ichiro Nakagawa and 6 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Nature microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 65 citations in OpenAlex.

  1. TMAO Correlates with Transcriptomic Signatures of Leukocyte Activation and Systemic Inflammation Following Burn Injury.Journal of burn care & research : official publication of the American Burn Association · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Secreted Aspartic Proteinases: Key Factors inInternational journal of molecular sciences · 2024
    Review
  11. Article
  12. Article
  13. Identification of the hybrid geneFrontiers in immunology · 2024
    Article
  14. Review
  15. LILRB4, an immune checkpoint on myeloid cells.Blood science (Baltimore, Md.) · 2022
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Kouyuki HirayasuLaboratory of Immunochemistry, WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, Japan.
Fumiji SaitoDepartment of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan.
Tadahiro SuenagaLaboratory of Immunochemistry, WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, Japan.
Kyoko ShidaLaboratory of Immunochemistry, WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, Japan.
Noriko AraseDepartment of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan.
Keita OikawaDepartment of Otolaryngology, Tenshi Hospital, Sapporo, Japan.
Toshifumi YamaokaDepartment of Dermatology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
Hiroyuki MurotaDepartment of Dermatology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
Hiroji ChibanaMedical Mycology Research Center, Chiba University, Chuo-ku, Chiba 260-8673, Japan.
Ichiro NakagawaDepartment of Microbiology, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan.
Tomoko KuboriLaboratory of Combined Research on Microbiology and Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan.
Hiroki NagaiLaboratory of Combined Research on Microbiology and Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan.
Yuji NakamaruDepartment of Otolaryngology-Head and Neck Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido 060-8638, Japan.
Ichiro KatayamaDepartment of Dermatology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
Marco ColonnaDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Hisashi AraseLaboratory of Immunochemistry, WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, Japan.ORCID 0000-0002-1153-3166
The University of Osaka · JPChiba University Hospital · JPHokkaido University · JPKyoto University · JPTenshi Hospital · JPWashington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbial proteases degrade a variety of host proteins(1-3). However, it has remained largely unknown why microorganisms have evolved to acquire such proteases and how the host responds to microbially degraded products. Here, we have found that immunoglobulins disrupted by microbial pathogens are specifically detected by leukocyte immunoglobulin-like receptor A2 (LILRA2), an orphan activating receptor expressed on human myeloid cells. Proteases from Mycoplasma hyorhinis, Legionella pneumophila, Streptococcus pneumonia and Candida albicans cleaved the N-terminus of immunoglobulins. Identification of the immunoglobulin-cleaving protease from L. pneumophila revealed that the protease is conserved across some bacteria including Vibrio spp. and Pseudomonas aeruginosa. These microbially cleaved immunoglobulins but not normal immunoglobulins stimulated human neutrophils via LILRA2. In addition, stimulation of primary monocytes via LILRA2 inhibited the growth of L. pneumophila. When mice were infected with L. pneumophila, immunoglobulins were cleaved and recognized by LILRA2. More importantly, cleaved immunoglobulins were detected in patients with bacterial infections and stimulated LILRA2-expressing cells. Our findings demonstrate that LILRA2 is a type of innate immune receptor in the host immune system that detects immunoglobulin abnormalities caused by microbial pathogens.

Indexed as

AnimalsBacteriaCytokinesHumansImmunity, InnateImmunoglobulinsLegionella pneumophilaLegionnaires' DiseaseMiceMonocytesMycoplasma hyorhinisNeutrophilsPeptide HydrolasesReceptors, ImmunologicStreptococcus pneumoniaeCytokinesImmunoglobulinsLILRA2 protein, humanPeptide HydrolasesReceptors, Immunologic

Identifiers

PMID27572839
OpenAlexW2345224147

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.